about
Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study.Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic reviewDeterminants of neurological disease: Synthesis of systematic reviews.Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite studyFatigue and Comorbidities in Multiple Sclerosis.A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada.The systematic search for risk factors in multiple sclerosis.Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.Genetic variation associated with the occurrence and progression of neurological disorders.Comorbidity is associated with pain-related activity limitations in multiple sclerosis.From bugs to brains: The microbiome in neurological health.Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.Drug exposure and the risk of multiple sclerosis: A systematic review.Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records.Comorbidities Are Associated with Altered Health Services Use in Multiple Sclerosis: A Prospective Cohort StudyFamilial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study
P50
Q31043617-6DE309BD-03BE-4FA5-8687-3B0CD583859FQ33610126-B163E1D5-36BA-4029-B2AA-2FE398742ED2Q35087429-E98E19CA-AB06-4CBB-9FF6-F99251356326Q36347408-D9683427-9A27-4404-A311-643139A912B8Q36761761-16611B28-80C4-4198-B13F-6FD3B2B6D1E9Q36848184-EF2B75C2-13A0-4ACD-9FDD-DB73C3A80AC4Q37252462-62D194CC-3D66-4773-8EA9-23F7F17EC218Q38348316-2E5B37D6-3920-4DCA-A032-896BE5CE0862Q38798498-D6C1DD32-03C4-47F7-BCB4-FEE3EF53DF49Q40551429-0107BCD7-4193-4B7B-B289-7937A68C3200Q41394307-D26E9ECD-E1B2-46D4-961C-F901250651AEQ43609758-B9779F97-E469-48CE-BCD0-2A00B572DD54Q47286241-4EC50E9A-1876-46F8-A02A-46B24C188B83Q47930462-1962E467-C3B8-4F1A-AF2B-108252DCD75FQ48208410-990B09CD-4C7D-4EDB-86CF-5122ACC468EDQ63816203-8350FD3C-E5FD-4090-AA20-3A9F4626F424Q90712184-3206688A-F4FB-47C3-95E8-9AE5EF49DC8E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kyla A McKay
@ast
Kyla A McKay
@en
Kyla A McKay
@es
Kyla A McKay
@nl
type
label
Kyla A McKay
@ast
Kyla A McKay
@en
Kyla A McKay
@es
Kyla A McKay
@nl
prefLabel
Kyla A McKay
@ast
Kyla A McKay
@en
Kyla A McKay
@es
Kyla A McKay
@nl
P106
P31
P496
0000-0002-9081-1522